Blood Plasma Market Size, [By Component Type (Albumin, Hyper immunes, Coagulation Factor Concentrates, Plasma Fractionation Products, Immunoglobulins), By Application (Transplant, Immunology, Oncology, Neurology, Pulmonology, Rheumatology, Haematology, Others), By Mode of Administration (Infusion Solution, Sprays, Biomedical Sealants, Gel), By End Use (Hospitals, Clinics, Research Laboratories)]; and Geography - Trend, Analysis and Forecast till 2025

Report Summary

The Global Blood Plasma Market Size is anticipated to grow at an effective rate owning to the factors such as rising need for isolation of plasma, and increasing governments efforts that promotes the blood donation in various countries.

Blood plasma is a yellowish coloured component of blood which comprises of 55% of total blood volume. Plasma is the extracellular matrix of the blood cells that contains water, proteins, glucose, clotting factors, electrolytes, hormones, carbon dioxide, and oxygen. Plasma plays an important role in an intravascular osmotic effect that maintains the balance between electrolytes that protects the body from infections and blood diseases. Moreover, plasma serves variety of functions, like balancing a satisfactory blood pressure level and monitors the volume critical proteins that play a significant role in blood clotting and immunity. Plasma also serves as a useful medium for the exchange of vital minerals such as potassium and sodium, and also serves to preserve a proper pH of blood.

When an individual donates blood the plasma can be isolated by the professionals. The blood plasma is separated from blood by spinning tube in a centrifuge containing an anticoagulant until the blood cells settle in the bottom of the tube. The plasma that is isolated that can be stored for a year. Plasma derivatives are derived with the help of fractionation. These derivatives are used for treating disorders like HIV, hepatitis B, and hepatitis C.

Rising investments for research and developments for the plasma isolation & its use as an effective treatment for treating chronic diseases, and increasing awareness for donating plasma in the emerging economies, to support the growth of global blood plasma market Size

The global blood plasma market size is primarily driven by the factors such as increasing awareness for the use of plasma derivatives as an effective treatment for diseases like hepatitis B, C, and HIV. Moreover, the growing number of plasma donation globally would add on the growth of this particular market. Additionally, the government initiatives for motivating the individuals to donate blood has also spurred the blood plasma market in the recent past. Similarly, increased government funding for the improvement of healthcare infrastructure in the developing countries to anticipate the growth of entire industry.

While, increasing number of plasma donors along with the strong presence of R&D facilities in North America, and rising number of CIDP patients has increased the demand for plasma donation to propel the growth of this industry in near future. Growing R&D funding and investments by the governments of developing economies, to spur the blood plasma market in coming years.

However, high cost of treatment option, and relatively lengthy approval process for this type of drugs, high cost of handling, and research & development might hinder the growth of blood plasma market in the near future.

Global Blood Plasma Market Taxonomy

The global blood plasma market size is segmented on the basis of product type, application, mode of administration, end users, and geography.

On the basis of component type, blood plasma market is segmented into:

• Albumin
• Hyper Immunes
• Coagulation Factors Concentrates
• Plasma Fractionation Products
• Immunoglobulins
• Immunoglobulin A (IgA)
• Immunoglobulin E (IgE)
• Immunoglobulin G (IgG)
• Immunoglobulin M (IgM)
• Immunoglobulin D (IgD)

On the basis of application, blood plasma market is segmented into:

• Transplant
• Immunology
• Oncology
• Neurology
• Pulmonology
• Rheumatology
• Haematology
• Others

On the basis of mode of administration type, blood plasma market is segmented into:

• Infusion Solutions
• Spray
• Biomedical Sealants
• Gel

On the basis of end use, blood plasma market is segmented into:

• Hospitals
• Clinics
• Research Laboratories

Geographically, the global blood plasma market size is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Increased expenditure on R&D for developing new and effective treatments with the help of plasma, and dynamic market condition to lead the global blood plasma market size in North America.

Geographically, the global blood plasma market to be segmented as North America, Europe, Asia Pacific, Latin America & Middle East and Africa. North America is expected to dominate the global blood plasma market over the forecast period. The major factors contributing the evolution of blood plasma market in North America are the changing market dynamics with continuous research and development on plasma, and increasing investment for the betterment of healthcare infrastructure in the U.S. and Canada.

然而,亚太市场观察更快growth during the forecast period. Increasing awareness for the donation of plasma, government initiative for encouraging the individuals for donating plasma, and elevating demand for albumin in the emerging economies to govern the global blood plasma market during upcoming years.

关键球员the global blood plasma market are:

• Grifols, S.A.
• CSL Limited
• Octapharma, Inc.
• Shire Plc.
• Bayer Healthcare AG.
• Biotest Pharmaceutical Corporation
• Beijing Tiantan Biological Products Co. Ltd.
• Kedrion S.p.A
• Adma Biologics, Inc.
• Hualan Biological Engineering Inc.